ORGANOGENESIS HOLDINGS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.815 USD | +1.62% |
|
-1.05% | -31.17% |
| May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
| May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Other Biotechnology & Medical Research | +1.62% | -1.05% | -31.17% | -17.45% | -60.52% | 367M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ORGO Stock
- Charts Organogenesis Holdings Inc.
- Comparison Chart
